Search alternatives:
significant groups » significant group (Expand Search), significant gradual (Expand Search), significant amount (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search), largest decrease (Expand Search)
groups decreased » group decreased (Expand Search), groups received (Expand Search), groups treated (Expand Search)
significant groups » significant group (Expand Search), significant gradual (Expand Search), significant amount (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search), largest decrease (Expand Search)
groups decreased » group decreased (Expand Search), groups received (Expand Search), groups treated (Expand Search)
-
41
-
42
-
43
Podocyte specific KO of FcRn results in a significant decrease in glomerular crescents 8 days after anti-GBM disease induction.
Published 2020“…Podocyte-specific KO of FcRn results in a significant decrease in the number of crescents (a, p = 0.035).…”
-
44
Podocyte specific KO of FcRn results in a significant decrease in albuminuria, glomerulosclerosis, and glomerular crescents after nephrotoxic serum nephritis induction.
Published 2020“…Right panel: Glomerulosclerosis score in control and podFcRn KO mice (n = 8 control and n = 7 podFcRnKO mice per group). Podcyte-specific KO of FcRn results in significant decrease in glomerulosclerosis score compared to control mice (p = 0.03). …”
-
45
Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity.
Published 2024“…(<b>C</b>) Pyr at 500 μM significantly decreased axon length ratio over time and was significantly lower than PBS control by day 3. …”
-
46
-
47
-
48
-
49
-
50
Predictors of coronary hyperemic DPV decrease after percutaneous coronary intervention.
Published 2024Subjects: -
51
-
52
-
53
-
54
Dengue virus infection significantly changes cellular organic acid contents.
Published 2024Subjects: -
55
Changes in BIS and PLE after administration of study drug at the end of surgery.
Published 2021Subjects: -
56
-
57
FASN Expression in OA and RA–shows that FASN is also significantly downregulated in the disease groups for OA and RA, suggesting its decreased activity might influence disease mechanisms or progression.
Published 2024“…<p>FASN Expression in OA and RA–shows that FASN is also significantly downregulated in the disease groups for OA and RA, suggesting its decreased activity might influence disease mechanisms or progression.…”
-
58
-
59
-
60